R
Power Law company profile
Rocket Pharmaceuticals
Biotech & Life Sciences · Cranbury Township, United States · Founded 2015 · IPO 2018 Unicorn
Valuation
$216M
Market cap · Apr/2026
Global footprint
Where Rocket Pharmaceuticals has talent and traffic
Web traffic by country
21K
monthly visits
across markets
across markets
🇺🇸 United States81%
🇬🇧 United Kingdom7.6%
🇮🇳 India7.1%
🇵🇭 Philippines2.4%
Patent intelligence
$4M patent portfolio · 5 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$4M
1.8% of market cap · 509.2× smaller than top peer Ablynx ($2B)
5 active patent families
Where Rocket Pharmaceuticals innovates
Molecular biologyCell biologyMedicinePolynucleotideGene Modification
Above peer median on Legal, Market, Economic, Technology
Quality vs same-sector peers
Rocket Pharmaceuticals on the five Patsnap quality dimensions
Rocket Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Rocket Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Rocket Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Rocket Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.